Introduction
Hematopoiesis involves the coordinate activation of genetic programs that control the processes of lineage commitment and maturation (Shivdasani and Orkin, 1996) .
The genes that take part in chromosome rearrangements of human acute leukemias are most likely involved in the control of dierentiation and proliferation. Many of these genes are important regulators of normal hematopoiesis (Sawyers et al., 1991; Rabbitts 1991 ). The t(15;17) chromosomal translocation, found at molecular level in over 95% of patients with acute promyelocytic leukemia (APL), involves the retinoic acid receptor a (RAR a) gene on chromosome 17 and the PML gene on chromosome 15, generating the PML/ RARa fusion gene that encodes fusion proteins (Warrell et al., 1993; Grignani et al., 1994) . The PML/RARa protein plays a major role in the pathogenesis of APL . Expression of PML/RARa in myeloid cell lines blocks dierentiation and decreases sensitivity to apoptotic cell death (Grignani et al., 1993 Rousselot et al., 1994) . In addition, PML/RARa transgenic mice develop an APL-like leukemia (Grisolano et al., 1997; He et al., 1997b; Brown et al., 1997) . The PML protein-dimerization and RARa DNA binding domains must interact to ensure the biological activity of PML/RARa (Perez et al., 1993; Grignani et al., 1996) . This ®nding suggests that the biological eects of the fusion protein depend on the alteration of both RARa and PML function, the latter possibly mediated by protein-protein interactions (Grignani et al., 1996) . A role in normal hematopoietic differentiation has been established for RARa (Kastner et al., 1992) ; however, little is known about the physiological function of PML. Ablation of murine PML protein by homologous recombination revealed a possible role for PML in the control of cell proliferation and differentiation of hematopoietic precursors, possibly mediated via interaction with the RA pathway (Wang et al., 1998) . Therefore, the study of PML protein expression and role in normal hematopoiesis is relevant for the comprehension of both the pathogenesis of APL and the physiology of hematopoiesis.
PML is a phosphoprotein associated with the nuclear matrix and expressed in most tissues (Daniel et al., 1993; Chang et al., 1995) . It belongs to a large family of proteins with common structural features, including a RING motif, two additional Cys/His-rich regions, named B-boxes and a coiled coil region, through which PML is able to form homodimers and, in APL cells, heterodimers with PML/RAR (Kastner et al., 1992; Goddard et al., 1991; Reddy et al., 1992; Borden et al., 1995 Borden et al., , 1996 . Within the nucleus, the PML protein is mainly localized in speci®c subdomains, the PML nuclear bodies (PMLNBs) (Dyck et al., 1994) . In APL cells the PML-NBs are disrupted and PML colocalizes with PML/RARa in novel structures called microspeckles (Dyck et al., 1994; Koken et al., 1994; Weis et al., 1994) . The delocalization of PML by PML-RARa, is associated with cellular transformation and can be reversed by treatment of cells with RA, that induces reaggregation of PML-NBs, and cellular dierentiation (Dyck et al., 1994; Koken et al., 1994; Weis et al., 1994) . Similarly, APL patients achieve clinical remission after all-trans RA therapy (Huang et al., 1988; Castaigne et al., 1990; Warrell et al., 1991) . These observations suggest that integrity of the PML function is required in normal hematopoiesis and that protein-protein interactions occurring within the PML NBs are relevant for normal hematopoietic dierentiation. The disruption of PML NBs is also caused by cytomegalovirus (Ahn and Hayward, 1997) , herpes virus (Everett and Maul, 1994; Everett et al., 1997) and adenovirus infection (Doucas et al., 1996) , as a consequence of the interaction of viral proteins with the PML NB protein complexes (Ahn et al., 1998) .
The biological activity of PML is still under investigation. PML has been regarded as a growth regulator (Mu et al., 1994; Liu et al., 1995; He et al., 1997a; Guiochon-Mantel et al., 1995) . Indeed, when overexpressed, it suppresses: (i) anchorage-independent growth of APL-derived NB4 cells (Mu et al., 1994) ; (ii) oncogenic transformation of rat embryonic ®broblasts by cooperative oncogenes and of NIH3T3 cells by activated Neu ; and (iii) growth and tumorigenicity of prostate cancer cells (He et al., 1997a) . These ®ndings suggest that PML shares many properties with tumor suppressors. The molecular pathway through which PML exerts its function remains unknown, although it has been suggested that PML can act as a transcription coregulator (Guiochon-Mantel et al., 1995) .
The PML protein may also be involved in the regulation of normal hematopoiesis as suggested by its role in cell growth control (Wang et al., 1998; Mu et al., 1994) and gene transcription block in APL (Grignani et al., 1993; Daniel et al., 1993) .
We have investigated PML gene expression and function in highly puri®ed human adult HPCs induced to proliferate and dierentiate to terminal stages along the erythroid (E) or granulopoietic (G) lineage (Labbaye et al., 1995) . We show here that PML expression is regulated during normal hematopoiesis in a dierentiation and lineage-dependent manner and is required in early hematopoiesis and E, but not G, maturation.
The pattern of PML expression in HPCs resembles that of pRb 105 . pRb 105 may exert its biological functions by interacting with other proteins (Chen et al., 1996a, b) as in the case of viral proteins which are implicated in PML-NB disruption during infection (Nevins, 1992) . In this regard, we show that PML and Rb proteins functionally and physically interact in erythropoiesis.
Results

Expression of PML mRNA in HPC erythroid (E) or granulopoietic (G) cultures
We have previously reported a puri®cation procedure for early HPCs from adult peripheral blood. The
Step IIIP cell population obtained by this procedure (CFU-GEMM, BFU-E and CFU-GM) is characterized by 490% CD34 + cells and 90 ± 95% HPC frequency Giampaolo et al., 1994; Labbaye et al., 1995) . In FCS 7 liquid suspension culture, these cells undergo selective proliferation and dierentiation along the erythroid pathway, upon addition of very low amounts of IL-3 and GM-CSF and a saturating level of Epo, or for the granulopoietic neutrophilic lineage, upon addition of low-dose IL-3+GM-CSF and saturating G-CSF level Labbaye et al., 1995) . In the ®rst week of culture, HPCs show a high proliferative activity which is associated with their progressive dierentiation, as evidenced by the progressive decline of CD34 + cells (Figure 1 ). In the second week we observed the disappearance of CD34 + and blasts and the progressively increasing expression of speci®c membrane markers for E and G precursors (e.g. glycophorin A and CD15, respectively) ( Figure 1) ; cell morphology analysis showed a gradual wave of maturation along the E and G pathway to terminal cells, i.e., at day 14, 97+2% erythroid cells (largely orthochromatic normoblasts) in E cultures, and '98% granulopoietic cells in G culture (largely mature neutrophils) (Figure 1) .
To evaluate the expression of PML mRNA in dierentiating HPCs, RNA samples were generated at sequential days from Step IIIP HPCs dierentiating along the E or G pathway. Three independent RT ± PCR experiments were performed. A series of controls, including dose-response curves for the assayed templates (not shown), ensured a semiquantitative evaluation of mRNA levels (representative results are shown in Figure 2a ). PML mRNA, is barely expressed in quiescent HPCs and is rapidly induced through the ®rst week of culture in both E and G culture. In the second week, high levels of PML-mRNA expression are sustained through terminal maturation (days 7 ± 13) in the E pathway. In the G lineage, PML-mRNA expression is downregulated at early granulopoietic precursor stage (days 7 ± 11 of culture) and is virtually abolished through terminal maturation (day 13) (Figure 2a ).
Expression of PML protein in dierentiating HPC cultures
We then monitored the kinetics of PML protein expression by indirect immuno¯uorescence. In differentiating HPCs, an anti-PML mAb labeled nuclear structures as previously described (Flenghi et al., 1995) for PML NBs (Figure 2b and c) . At day 0, quiescent HPCs displayed low nuclear PML expression. Initial dierentiation of HPCs along the E or G pathway was associated with a marked induction of PML, as suggested by the increase of¯uorescence staining (Figure 2b and c, day 5). In the second week, PML expression was still elevated in dierentiating E culture (days 7 ± 11) ( Figure 2b ) abruptly declines in G culture after day 9 and almost completely disappears in mature granulopoietic cells (G, day 13) (Figure 2c ). PML protein expression during E and G dierentiation was quantitated by counting the number of PODs detected by immuno¯uorescence staining (see Table 1 ). This analysis showed that the number of PODs peaks at days 3 ± 5 in G cultures and at days 5 ± 7 in E cultures; at later times of culture although the number of PODs per cell declines both in E and G cells, this phenomenon is much more pronounced in the G lineage (see Table 1 ).
To con®rm these data, we performed Western blot analysis of nuclear extracts prepared from HPCs harvested at day 9 and day 12 of E or G cultures, respectively ( Figure 3 ). Consistent with previous reports (Nason-Burchenal et al., 1996) , the PG-M3 mAb used to detect the PML proteins (Flenghi et al., 1995) , recognizes several PML isoforms, originated by dierential mRNA splicing , with bands of 90 and 70 K d (Figure 3 ). PML protein was abundant in day 9 and 12 erythroblasts, whereas it was sharply downmodulated in granulopoietic precursors ( Figure 3 ). As a positive control for one of the PML isoforms we used a U937 cell line clone stably transfected with a PML3 cDNA (Flenghi et al., 1995) . Overall, protein data strictly paralleled mRNA expression.
Eect of PML antisense oligodeoxynucleotide on HPC E and G colony formation
We examined the role of PML in hematopoietic dierentiation by inhibiting PML protein expression with phosphorothioate antisense oligodeoxynucleotide to PML mRNA (Figure 4a and b). Antisense oligomers were added to dierentiating HPCs stimulated by hematopoietic growth factors to form erythroid (BFU-E) and/or G (CFU-G) colonies. Control cultures were mock treated with equivalent amounts of the scrambled antisense oligomers. We have used two sets of phosphorothioate antisense PML oligomers in our experiments.
HPCs treated at day 0 showed a marked dosedependent inhibition of both E and G colonies ( Figure  4a ). Both sets of antisense oligomers (a1-PML, a2-PML) gave similar inhibitory patterns. However the ®rst set was preferred because the scrambled a1-PML was absolutely neutral in our assay while the scrambled a2-PML gave * 20% non speci®c inhibitory eect. In addition the antisense a2-PML was less ecient in inhibiting both the E and the G cultures than the antisense a1-PML (Figure 4a ). Treatment at day 5 after growth factor addition, selectively inhibited E, but not G, colonies (Figure 4b ). Scrambled oligomer a1-PML treatment had no eect on colony formation at either culture time (Figure 4a and b). Step III P HPCs, as evaluated at sequential days. The morphology of erythroid and granulocytic dierentiation was classi®ed according to progressive stages which include: (i) for the E series blasts, proerythroblasts (pro.) basophilic erythroblasts (Baso. Erythr.), polychromatophilic erythroblasts (Poly.) and orthochromatic erythroblasts (ortho.); for the G series, blasts, myeloblasts (myelob.), promyelocytes (promyelo.), metamyelocytes (metamyelo.), band granulocytes (band granulo.) Control experiments showed that antisense oligomer treatment clearly decreased PML protein expression in day 3, 5, and 9 in E and G cultures, as evaluated by immuno¯uorescence analysis (Figure 5a and Table 2 ) and markedly reduced PML mRNA expression (Figure 5b ). Scrambled oligomer treatment had no eect on expression of either PML protein (data not shown) or RNA (Figure 5b) . Particularly, IF analysis showed that antisense oligomer treatment elicited a marked decrease of the number of PODs, while a b Expression and role of PML and Rb proteins in erythropoiesis C Labbaye et al oligomer scrambled treatment had no eect on this parameter (Table 2) .
Functional synergism and molecular interaction of the PML and Rb proteins in normal erythroid progenitor cells
The described pattern of PML expression is similar to that previously described for Rb protein along the E and G lineages . Thus, we investigated a possible physical and functional interaction between PML and Rb in erythroid cells. a-Rb and a1-PML oligomers were simultaneously added, at day 5 after growth factor addition, to dierentiating HPCs induced to E or G differentiation. Control cultures were mock treated with equivalent amounts of the scrambled antisense oligomers, a-Rb plus scrambled oligomers or a1-PML plus scrambled oligomers ( Figure 6 ). Expression of both PML and Rb proteins was markedly reduced by this treatment in both culture types (not shown). The development of G colonies was not signi®cantly altered (not shown), whereas very low doses of combined a1-PML and a-Rb oligomers induced a marked inhibition of erythroid colony formation (Figure 6 ). The eect of this antisense oligomer combination was more than additive with respect to that of single a1-PML and aRb oligomers, indicating a functional synergism c Figure 2 (a) PML mRNA expression in puri®ed HPCs grown in liquid-phase unilineage erythroid (E) or granulopoietic (G) cultures, as evaluated by semi-quantitative RT ± PCR. b2-microglobulin (b2 m) was used for normalization. K562 cell line was the internal positive control. A negative control (7) is also included. One representative experiment of three independent experiments is shown. (b) Immuno¯uorescence labeling with PG-M3 anti-PML mAb of puri®ed HPCs and their progeny grown in erythroid (E) or, (c) granulopoietic (G) culture, as evaluated at sequential days. Fluorescent cells were examined under a Nikon microphot microscope equipped with a highly sensitive videocamera and a digital system for image acquisition (61000 magni®cation). Day 11 and day 13 granulopoietic cells were overexposed to allow the detection of the few faint PML NBs present in these cells To determine whether this synergism is based on a biochemical interaction of these two nuclear proteins in vivo, we performed reciprocal co-immunoprecipitation and Western blotting experiments of both PML and pRb105 proteins on cell lysates derived from HPCs at a late stage of E or G dierentiation (days 9 ± 11, Figure 7a and b). Nuclear protein extracts were prepared from HPCs harvested at days 9 ± 11 of E culture, at day 9 of G culture, from Rb + K562 cells and Rb 7 SAOS cells. Lysates were immunoprecipitated with either anti-pRb105 or anti-PML mAb (Figure 7a  and b) .
The anti-Rb immunoprecipitate was loaded onto two separate 8% SDS-PAGE gels and blotted on membranes. The two membranes were probed with anti-pRb105 and anti-PML (PG-M3) antibodies, respectively, and then revealed by a chemioluminescence procedure (Figure 7a) . Results showed that a major 90 KDa and a minor 70 kDa PML protein coimmunoprecipitate with the Rb protein in late E dierentiation (Figure 7a ). No PML/Rb complex was detected in late G dierentiation ( Figure 7a) . As a control, the ®lters were stripped and reprobed with the reciprocal antibody, con®rming the presence of the PML protein in anti-Rb immunoprecipitates (data not shown).
The PML immunoprecipitate was blotted together with a control anti-Rb immunoprecipitate. The membrane was probed with an anti-Rb polyclonal Ab (Figure 7b right panel) . PML immunoprecipitates from K562 cells were also evaluated. This experiment showed that anti-PML immunoprecipitates contain a low amount of a 105 kDa pRb, con®rming the presence of a PML/Rb complex in HPCs at day 9 of E culture (Figure 7b, right panel) . The eciency of PML immunoprecipitation was veri®ed in control experiments where anti-PML immunoprecipitates were blotted and probed with the anti-PML mAb (PG-M3) (Figure 7b, left panel) . The speci®city of the PML/Rb complex was controlled by co-immunoprecipitation/ Western blot experiments with PML and GATA-1 (Labbaye et al., 1995) . No PML/GATA-1 complex was detected at day 9 of E culture (data not shown).
Overall these ®ndings indicate the PML protein and a fraction of pRb105 speci®cally interact in day 9 E culture.
Discussion
Hematopoiesis is a multistep proliferation and differentiation process, which is sustained by a pool of hematopoietic stem cells (HSCs). HSCs are capable of (a) Immuno¯uorescence analysis of PML expression in HPCs dierentiating in unilineage E liquid culture upon treatment with an optimal concentration (100 mg/ml) of antisense oligomer to PML (a1-PML), or scrambled a1-PML. Oligomers were added on HPCs at day 0 of culture and the cells were analysed by immuno¯uorescence at sequential day after labeling with PG-M3 anti-PML mAb. (b) RT ± PCR analysis of PML expression in HPCs dierentiating in unilineage E liquid culture upon treatment with an optimal concentration (100 mg/ml) of antisense oligomer to PML (a1-PML), or scrambled a1-PML (Scr a1-PML) added at day 0 of culture. Cells were collected for RNA extraction at day 7 and day 9 from the culture Expression and role of PML and Rb proteins in erythropoiesis C Labbaye et al extensive self-renewal and feed into lineage-committed HPCs. We have developed methodology for normal HPC/HSC puri®cation (Gabbianelli et al., 1990; Labbaye et al., 1994) and unilineage dierentiation/ maturation in liquid-phase suspension culture: this allows a step-by-step analysis of hematopoietic dierentiation/maturation through a single lineage at both cellular and molecular levels (Labbaye et al., 1994 (Labbaye et al., , 1995 Giampaolo et al., 1994; Condorelli et al., 1995) .
We have exploited this model system to investigate the pattern of expression and the possible role of several transcription factors in hematopoietic differentiation (Labbaye et al., 1994 (Labbaye et al., , 1995 Giampaolo et al., 1994; Condorelli et al., 1995) . The relevance of PML in the physiology of the hematopoietic system is indirectly suggested by its involvement in the pathogenesis of APL as a partner of RARa in the PML/RARa fusion protein (Warrell et al., 1993; Grignani et al., 1994; de TheÁ et al., 1991) and is also directly supported by the phenotypic analysis of PML 7/7 mice (Wang et al., 1998) . This rearrangement is much more frequently observed as compared with other known APL fusionproteins, PLZF/RARa (Chen et al., 1993) , NPM/ RARa (Redner et al., 1996) and NuMA-RARa (Wells et al., 1997) reported in M3 leukemias. In addition, PML possesses structural and functional features of a transcription factor (Kastner et al., 1992; Guiochon-Mantel et al., 1995) , and biological activity of a growth regulator (Mu et al., 1994) . PML mRNA and protein expression is low in quiescent HPCs and is induced by growth factor stimulation of Figure 6 Eect on BFU-E colony formation upon HPCs treatment with appropriate concentrations of (i) antisense (AS) oligomer to PML (a1-PML), (ii) antisense oligomer to Rb (a-Rb), (iii) scrambled a1-PML (Scr a1-PML) and/or (iv) scrambled a-Rb (Scr aRb), added alone or in combination as indicated at day 5 of culture. Total oligomer dosage is indicated (mg/ml): combined treatment involved equal amounts of the two oligomers. **P50.01 when compared with control groups treated with the same dosage of scrambled oligomers (Scr a1-PML+Scr a-Rb; Scr a-Rb+a1-PML; Scr a1-PML+a-Rb). 88P50.01 when compared with all other groups treated with 50 mg total oligomer dosage. *P50.05 when compared with control scrambled a1-PML (Scr a1-PML) group. When a combination of two oligomers was used, half dose of each oligomer was added (i.e. column 15; total dose 50 mg/ml: 25 mg/ ml a1-PML+25 mg/ml Scr a-Rb) both E and G dierentiation. Subsequently, during precursor maturation, PML mRNA and protein expression is maintained in the E series, but is down modulated in the G pathway. Notably, in another series of experiments, we observed that PML is expressed during megakaryocytic dierentiation (unpublished results), suggesting that it is speci®cally suppressed during late G maturation. The antisense oligomer approach allowed an insight into the possible functional role of PML in the normal hematopoietic dierentiation process. Suppression of PML protein expression in early HPCs (day 0 of culture) markedly inhibits both BFU-E and CFU-G colony formation. This ®nding suggests that the PML protein is required in early normal hematopoiesis, possibly playing a role in the control of HPC cell cycling. Subsequently, in more advanced HPCs (day 5 of culture), suppression of PML expression induces a dose dependent inhibition of late BFU-E, but not CFU-G, colony formation. These data con®rm the hypothesis that the PML protein is required for erythroid maturation, but is dispensable for late granulocytic dierentiation.
These data are also relevant for the understanding of the biological function of the normal PML protein.
PML is required for both early hematopoiesis and E colony development, and thus cannot be regarded simply as a growth controller, but must also have a tissue-speci®c function in the control of cell cycle and dierentiation, possibly through interaction with tissuespeci®c nuclear proteins.
The modulation of PML expression during HPC dierentiation and precursor maturation, is very similar to that described for another nuclear phosphoprotein, pRb105, known as a tumor suppressor . pRb is a master regulator of cell cycle progression and dierentiation (Chen et al., 1996a,b and for review see Taya, 1997) . Many of the functions of Rb depend on its association with other proteins. In this context, several groups have recently documented the apparent role of pRb in terminal cell dierentiation through its capacity to directly interact with and activate speci®c TFs, such as NF-IL6 in monocyte/macrophage precursors (Chen et al., 1996b) or other members of the CAAT/enhancer-binding protein (C/EBP) family in adipocyte culture (Chen et al., 1996a) .
In the present experiments, separate addition of suboptimal concentrations of a-Rb and a1-PML oligomers slightly inhibited day 0 HPC differentia- Figure 7 (a) Western blot analysis of nuclear extracts immunoprecipitated with anti-pRb105 mAb X55 from: 4610 6 day 9 or day 11 E, day 9 G cells and from 2610 6 K562 or SAOS-2 cells. The immunoprecipitated materials were analysed by 8% SDS ± PAGE. After blotting, (i) the membrane was ®rst treated with a polyclonal anti-pRb105 (left panel); as expected, pRb is not detectable in SAOS-2 extracts; (ii) the same membrane was then treated, after stripping, with anti-PML mAb PG-M3 (right panel). (b) Western blot analysis of nuclear extracts immunoprecipitated with anti-PML mAb, PG-M3 or with anti-pRb105 mAb, XZ55, from 4610 6 day 9 E cells. The immunoprecipitated materials were analysed by 8% SDS ± PAGE. After blotting, (i) one membrane was treated with anti-PML mAb, PG-M3, showing two major bands corresponding to the dierent isoforms (de TheÁ et al., 1991) at approximately 90 and 70 KDa, respectively (left panel); (ii) a second membrane was treated with anti-pRb105 polyclonal Ab, SC-15, showing the pRb105 band (right panel) tion. Simultaneous oligomer addition completely blocked E, but not G maturation, in day 5 E and G cultures. This eect seems to be synergistic, suggesting that PML and Rb cooperate in the regulation of erythropoiesis. The functional interaction between PML and Rb may consist in a coordinate activity of the two proteins on the same molecular pathways. However, pRb105 co-immunoprecipitates with the PML protein from erythroid precursors, suggesting that the biological eect of the functional PML and Rb knock-out may derive from the decrease of a proteic complex containing both PML and Rb. Indeed, using cell lines, we have recently demonstrated and mapped the physical PML/Rb interaction within PML-NBs: interestingly, PML can modulate RB activity on the glycocorticoid receptor gene promoter (Alcalay et al., 1998) . The co-immunoprecipitation experiments shown here were performed in normal cells and did not involve overexpression of the interacting proteins, supporting the notion of the existence of a physiological PML/Rb complex in normal cells.
We observed PML/Rb coimmunoprecipitation only after a long exposure of the membranes. This ®nding indicates that the amount of PML-Rb complex in erythroblasts accounts for a small proportion of the total pRb protein, which may localize within the PML NBs (Alcalay et al., 1998) . The speci®c function of the interacting subfractions of the two proteins is presently unknown, but it may consist in the formation of speci®c protein-protein interactions.
Our ®nding that PML and Rb are required for erythroid dierentiation, and that the two proteins physically interact in maturing erythroid cells, provides the ®rst evidence for a functional role of the PML/Rb complex, speci®cally in normal hematopoiesis.
Materials and methods
Hematopoietic growth factors and cell culture
Recombinant human growth factors were obtained from standard commercial sources (Gabbianelli et al., 1990; Labbaye et al., 1994 Labbaye et al., , 1995 Giampaolo et al., 1994) . Iscove's medium (IMDM, GIBCO) was freshly prepared weekly. Cell lines used as controls for Western blotting and immunoprecipitation experiments (K562, Jurkat, SAOS-2, U937-PML3) were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS).
Adult peripheral blood (PB) HPC puri®cation and clonogenetic assay
HPCs were puri®ed from the PB buy coat according to the method previously reported (Gabbianelli et al., 1990 ) and subsequently modi®ed as described Labbaye et al., 1995) . Puri®ed HPC clonogenetic cultures FCS 7 were supplemented with IL-3 (100 U/ml), GM-CSF (10 ng/ml) in presence or not of Epo (3 U) in order to obtain CFU-GM colonies or BFU-E plus CFU-GM colonies (Labbaye et al., 1995) .
HPC erythroid (E) and granulopoietic (G) liquid suspension culture
Step IIIP HPCs were seeded (5610 4 cells per ml) and grown in liquid FCS 7 medium (Valtieri et al., 1989) supplemented in E culture with low doses of IL-3 (0.01 U/ml) and GM-CSF (0.001 ng) and a saturating level of Epo (3 U) and in G culture with low amounts of IL-3 (1 U) and GM-CSF (0.1 ng) and a saturating amount of G-CSF (10 ng) as described (Labbaye et al., 1995) . Cells were incubated in a fully humidi®ed atmosphere of 5% CO 2 /5% O 2 /90% N 2 and were periodically counted and analysed for morphology, membrane phenotype, and PML gene expression.
Cell surface marker and morphology analysis
To evaluate the dierentiation of HPCs dierentiating along the E and G lineages the cells were labeled with the following monoclonal antibodies labeled either with FITC or PE: anti-CD34, anti-CD15, anti-CD11a and anti-Glycophorin A (Pharmingen, San Diego, CA, USA). Fluorescent cells were analysed with a¯ow cytometer (FACS Scan, Becton Dickinson, San Diego, CA, USA).
For cell morphology analysis cytospin preparations of cells were performed at dierent days of culture and stained with May ± GruÈ nwald ± Giemsa. At least 200 cells were examined and classi®ed according to their dierentiation/maturation stage.
Morphology and immuno¯uorescence analysis
Cells were harvested on dierent days, smeared on glass slides by cytospin centrifugation, and stained with May ± GruÈ nwald ± Giemsa. The anti-PML mAb PG-M3 (Flenghi et al., 1995) was used for immuno¯uorescence labeling of PML. Indirect immuno¯uorescence was performed as described (Grignani et al., 1996) . Cells were examined under ā uorescence microscope (Microphot, Nikon) equipped with a highly sensitive videocamera and a system for digital images acquisition.
Reverse transcriptase (RT ± PCR) mRNA analysis
The method for semiquantitative RT ± PCR analysis has been reported (Labbaye et al., 1994 . cDNAs were normalized by the b2-microglobulin gene (Labbaye et al., 1995) . K562 cell line was used as an internal positive control. An aliquot of RT ± RNA (20 ng) from each sample and a mock reaction (negative controls) were ampli®ed to exclude the presence of contaminant DNA. PML primers and probe were as follows: PML-sense 5'-(TTC GGA GGA GGA GTT CCA)-3' (from 219 ± 237); a-sense PML: 5'-(GTG TGC CTC GAA GCA CTT)-3' (from 527 ± 545); internal probe: 5'-(CTAGGTGCAGACACACCC-GCCCT)-3' (from 368 ± 391) (de TheÂ et al., 1991) . The ampli®cation procedure included denaturation at 958C for 30 s, annealing at 568C for 30 s, and extension at 728C for 45 s during 30 PCR cycles, i.e., within the range of linear ampli®cation this cycle number allowed a linear cDNA dose response. In control experiments, serial dilutions of samples were ampli®ed; the dose-response curves showed linearity for all points (not shown). Relative intensities of bands were quanti®ed by scanning with a laser densitometer (Phosphorimager Molecular Dynamics Inc.; Sunnyvale, CA, USA).
Protein extraction and Western blot analysis
Proteins were extracted from HPCs (4610 6 ) collected at day 9 and 12 from E and G cultures and analysed by Western blot as described in Grignani et al. (1996) . Samples were normalized for cell number and loaded onto 8% SDS-polyacrylamide gel. K562 cell line and U937-PML3 (U937 cells stably transfected with the PML3 cDNA (Flenghi et al., 1995) ) were used as positive controls. The anti-PML mAb PG-M3 (Flenghi et al., 1995) was used to probe the blotted membrane for PML. Bands were visualized by enhanced chemiluminescence (Amersham).
HPC oligomer treatment and clonogenetic assay
Oligomer treatment was performed as described in Labbaye et al. (1995) . We have used two sets of phosphorothioate oligodeoxynucleotides in our experiments.
Oligomers The following phosphorothioate oligodeoxynucleotides were used: (i) the ®rst set was, antisense PML (a1-PML): 5'-(CAT TGC TGG CAG CGC AGA)-3', complementary to nucleotides starting from 241 ± 259 PML mRNA coding sequence (de TheÁ et al., 1991) ; scrambled a1-PML (Scr a1-PML), 5'-(GGC ACG CCA TGC AGT AGT)-3', (ii) the second set was, antisense PML (a2-PML): 5'-(CAGACAAGGCAGCAGCTT)-3', complementary to nucleotides starting from 283 ± 301 PML mRNA coding sequence (de TheÂ et al., 1991) ; scrambled a2-PML (Scr a2-PML), 5'-(AACTGAGATCAAGGC-CGC)-3', (iii) antisense Rb (a-Rb), 5'-(GTGAACGA-CATCTCATCTAGG)-3' ; scrambled a-Rb (Scr a-Rb), 5'-(TACTGGCTAAGCC-TAGCATGA)-3'.
Oligomer treatment
Step IIIP cells were diluted in FCS 7 medium (5610 3 cells per ml) supplemented with hematopoietic growth factors for unilineage E or G dierentiation, in the presence or absence of antisense or randomly scrambled phosphorothioate oligomers at appropriate concentrations (25, 50 and 100 mg/ml) added either at day 0 or at day 5 and incubated overnight. Cells were then plated in clonogenetic culture in triplicate dishes as described elsewhere (Labbaye et al., 1995; Valtieri et al., 1991; CareÂ et al., 1994) .
Fluoresceinated oligomer uptake was evaluated as previously reported Labbaye et al., 1995) .
The anti-PML mAb PG-M3 (Flenghi et al., 1995) was used for immuno¯uorescence labeling of PML in E culture treated at day 0 with a1-PML or scrambled a1-PML (Scr a1-PML).
Immunoprecipitation and Western blot analysis
Nuclear extract preparation Nuclear extracts, prepared as described (Snow et al., 1987) were normalized for cell number from 4610
6 HPCs collected at day 9 and 11 of E culture, at day 9 of G culture, or from 2610 6 cells from dierent cell lines (K562 and Jurkat, for positive controls of PML and Rb proteins expression, respectively; SAOS-2 for negative control of Rb protein expression).
Immunoprecipitation was performed as described previously (Snow et al., 1987) with (i) anti-PML mAb, PG-M3 used at 1/50 dilution (Flenghi et al., 1995) ; or with (ii) antipRb105 mAb used at 1/1000 dilution .
Several controls were performed with nuclear extracts prepared from day 9 E culture: (i) immunoprecipitation of the transcription factor hGATA-1 (Labbaye et al., 1995) , using the anti-hGATA-1 mAb (Santa Cruz), to assay the speci®city of the PML/pRb complex; (ii) addition of IgG or beads alone to evaluate background in the immunoprecipitation procedure (data not shown).
Western blot analysis Immune complex samples were prepared in duplicate and loaded onto two dierent 8% SDS-polyacrylamide gels. Blotted membranes were probed: (i) ®rst, with anti-PML mAb, PG-M3 diluted 1/500 or with the anti-pRb105 polyclonal antibody, SC-15 (Santa Cruz) diluted 1/5000. (ii) After stripping, the membrane ®rst treated with anti-PML, was reprobed with anti-pRb105 polyclonal Ab, SC-15 and the membrane ®rst treated with the anti-pRb105 was reprobed with anti-PML mAb. Blots were visualized by Enhanced Chemiluminescence (Amersham).
